New: NCI-funded clinical trial search
Mednet Logo
CommunityRadiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How do you account for only a partial fraction of radiation being delivered due to machine malfunction?

2 Answers

Mednet Member
Radiation Oncology · Baylor Scott & White Health

For conventional fractionation, I have typically disregarded this partial dose and repeated that fraction at full dose unless it was >75%. For SBRT, in one case, half the dose was delivered in one arc. and the next day once the problem was fixed the patient received the second arc to complete that f...

What are your top takeaways from ASCO GU 2022?

4
6 Answers

Mednet MemberInvited Expert
Medical Oncology · Duke University School of Medicine

My top abstracts and questions that arise from them: 1) ARASENS with darolutamide in high volume de novo mHSPC showing an OS benefit with darolutamide over ADT/docetaxel. Will this pertain only to high volume/risk patients who are chemo-fit and de novo which seemed to comprise the vast majority of ...

How do you treat a low grade mucoepidermoid carcinoma with unkown primary site?

1 Answers

Mednet MemberInvited Expert
Radiation Oncology · University of Florida

A misnomer. Low grade MECs don’t metastasize so, if it does, it’s not low grade regardless of the histology. Neck dissection plus postop RT and include the potential primary site if feasible.

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

How do you manage lengthy unplanned breaks during radiation therapy for breast cancer?

1 Answers

Mednet Member
Radiation Oncology · University of Vermont Medical Center

Dr. @Dr. First Last et al published a consensus guide for responding to unanticipated delays in treatment for multiple cancer sites (PMID 30999000). For breast, the recommendation is to add 2Gy lumpectomy boost for each week of missed treatment, up to 66Gy. I found this advice helpful when we had a ...

How do you manage near-field recurrence of a soft tissue sarcoma that was previously treated with pre-op RT?

1 Answers

Mednet MemberInvited Expert
Radiation Oncology · The Ohio State University - James Cancer Hospital and Solove Research Institute

First, try to figure out what is really going on here. Local control rates for preop RT and resection--assuming both of those were done well--should be ~90%. So this situation should be unusual. Was a satellite lesion missed during initial diagnosis? Were volumes delineated correctly, including T2 F...

When is postmastectomy radiation therapy indicated for a de-novo occurrence of cancer in the chest wall after mastectomy without prior malignancy, such as in a patient who had prophylactic mastectomy?

1
1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network

This is such a rare occurrence and I may have done this a few times. I have usually limited to CW only if SNLN is done as part of surgery and is negative. That being said, feel local excision alone with adjuvant systemic treatment as indicated may be an option.

How do you manage real-time release of pathology and radiology results to oncology patients following enaction of the CURES act?

4
1 Answers

Mednet Member
Radiation Oncology · Karmanos Cancer Institute - McLaren Proton Therapy Center

Even prior to the Cures Act, I worked in a place where lab and imaging results were immediately available to patients through their smartphone app. A few memorable encounters: Patient 1 - told me his favorable PSA result when I walked in the room and basically told me the plan going forward, (which ...

What additional benefit does radiation offer for a patient <65 years old with T1aN0 ER+ invasive carcinoma (tubular histology) of the breast?

4
1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network

Most of these have low genomic scores and are part of the DEBRA trial and up until that, based on available evidence, would favor adjuvant RT (APBI preferred).

How do you manage new brain mets in a patient with a history of RT necrosis after prior SRS?

2
2 Answers

Mednet MemberInvited Expert
Radiation Oncology · University of Louisville School of Medicine

The short answer is “yes”. For brain mets over 2 cm in maximum diameter, we and others have found that 3-5 fraction stereotactic radiation therapy has produced equivalent or better local control and lower incidence of radionecrosis than single fraction stereotactic radiosurgery. It would be good if ...

How would you sequence treatment for HPV (+) concurrent advanced oropharynx and anal SCC?

1 Answers

Mednet MemberInvited Expert
Radiation Oncology · University of Florida

Treat concomitantly.